Dean A. Lee, MD, PhD, is the Director of the Cellular Therapy and Cancer Immunotherapy Program at Nationwide Children’s and the Ohio State Comprehensive Cancer Center. Dr. Lee earned his BA in Natural Sciences from Fresno Pacific College and his MD and PhD in Microbiology and Molecular Genetics from Loma Linda University. He completed his Pediatric Residency training at Loma Linda and his fellowship in Pediatric Hematology/Oncology at Texas Children’s Hospital, Baylor College of Medicine. He is the recipient of numerous research grants from CPRIT, St. Baldrick’s Foundation, CURE, Leukemia and Lymphoma Society, ASH, Alex’s Lemonade Stand and more to support his work in immunotherapy and cellular therapy, with special emphasis on NK cells. He has several ongoing and soon-to-be launched NK-based cellular therapy trials under FDA Investigational New Drug applications, and others in the pipeline for cancer and infectious diseases. His research has earned in patents and commercial licenses in the field of cellular therapy. Dr. Lee’s clinical interests include bone marrow transplantation and graft engineering for myeloid malignancies. His research interests include NK cell biology and immunotherapy.